INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority

Clinical trial NCT02832531 · WITHDRAWN

Trial details

NCT number: NCT02832531
Sponsor: Population Health Research Institute
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatic Heart Disease

Start date: 2022-01-01
Primary completion: 2022-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.